O

Oragenics
D

OGEN

0.28270
USD
0.00
(0.11%)
مفتوح الان
حجم التداول
1,405
الربح لكل سهم
-11
العائد الربحي
-
P/E
-0
حجم السوق
3,875,762
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Oragenics

القطاع: Healthcare
الصناعة: Biotechnology
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.